hyaluronoglucosaminidase has been researched along with Leishmaniasis, Cutaneous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amo, L; Calvo, E; Chagas, AC; DeSouza-Vieira, TS; Guimaraes-Costa, AB; Martin-Martin, I; Moore, IN; Oliveira, F; Ribeiro, JMC; Sanchez, EE; Suntravat, M; Valenzuela, JG | 1 |
NEAL, RA | 1 |
2 other study(ies) available for hyaluronoglucosaminidase and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection.
Topics: Animals; Computer Simulation; Endonucleases; Female; Host-Pathogen Interactions; Humans; Hyaluronoglucosaminidase; Insect Proteins; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Models, Molecular; Neutrophils; Polysaccharide-Lyases; Psychodidae; Rabbits; Saliva | 2018 |
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyribonuclease I; Emetine; Hyaluronoglucosaminidase; Hydrastis; Leishmania tropica; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Mice; Pathology; Pharmacology; Primaquine; Pyrimethamine; Quinacrine; Research; Streptodornase and Streptokinase; Streptokinase; Sulfonamides; Surface-Active Agents; Toxicology | 1964 |